Return to search

Unlocking the Potential of Precision Medicine: Implications for Health Plans

Event Date: 7/17/2019

Event Overview

Wednesday, July 17, 2019
1:00 PM CT – 2:00 PM CT (60 minutes)
Hosted by: McKinsey & Company

This event is hosted on our ReadyTalk platform

 

"Precision medicine" or "personalized medicine" is all the buzz. Tailoring medical treatment to the individual characteristics of each patient holds tremendous promise. But what are the implications for health plans? Our expert colleagues with McKinsey & Company will provide a strategic overview of this evolving field. Some topics health plan executives need to think through include:

  • Current landscape, innovations, and what health plans can expect in the future
  • Data used for precision medicine - genetic testing, epigenetics and more
  • Tying precision medicine to value-based care
  • Measures of success like outcomes, cost efficiencies and ROI


Audience

Health plan leaders and staff involved in clinical functions including care management, pharmacy, value-based care, and quality will find this webinar of value. Finance, technology, and strategy roles will also benefit from hearing what is in store for health plans.


Ask your peers a question or share a resource anytime through the Alliance discussion forum

You can visit the discussion forum and post a question anytime. It's only available to Alliance members, so you question is private and secure. When submitting a question, you can select which topics your question is related to. Individuals who have indicated in their Alliance profile they are interested in those topics and are opted in to discussion forum emails will receive your question. You can also add an attachment to your question or reply, making this tool another great resource for sharing best practices with your peers.

 


 

Other recommended events

 

Register now for these upcoming events

View the presentation materials from these recent events

 

Documents
7/17/2019

Presentation: Unlocking the Potential of Precision Medicine: Implications for Health Plans
McKinsey & Company present the latest in precision medicine and insights on how health plans can set themselves up for success.

7/17/2019

Recording: Unlocking the Potential of Precision Medicine - Implications for Health Plans
McKinsey & Company present the latest in precision medicine and insights on how health plans can set themselves up for success.

Attendees

Below is a list of all delegates registered to date for this event

  • Xuan Cung
  • ALLIANCE MEMBER
  • VHP Division Director of Pharmacy Services at Valley Health Plan
  • Brenda Hart
  • ALLIANCE MEMBER
  • Clinical Programs Pharmacist at Neighborhood Health Plan of Rhode Island
  • Don Hufford
  • ALLIANCE MEMBER
  • Innovation Strategist at Western Health Advantage
  • Thomas Irungu
  • ALLIANCE MEMBER
  • Medical Director at Sentara Health Plans (Optima)
  • Gregory Merti
  • ALLIANCE MEMBER
  • Medical Director at Sentara Health Plans (Optima)
  • Priti Mody-Bailey
  • ALLIANCE MEMBER
  • Chief Medical Officer/VP at Community First Health Plans
  • Marquisetta Robinson
  • ALLIANCE MEMBER
  • Supervisor Service Coordination/Care Management at Cook Children's Health Plan
  • Laurel Soot
  • ALLIANCE MEMBER
  • Interim Chief Medical Officer at Providence Health Plan
  • Teodor Todhe
  • ALLIANCE MEMBER
  • Clinical Quality of Care Manager at MetroPlusHealth
  • Chris Turoff
  • ALLIANCE MEMBER
  • Director of Pharmacy, Health Plan at MediGold
  • Rupal Malani
  • SPEAKER
  • Partner at McKinsey & Company at Mckinsey & Company
  • Erika Stanzl
  • SPEAKER
  • Engagement Manager at Mckinsey & Company
Speakers